Long-term results of surgical treatment of non-specific spondylitis: assessment of the quality of life and satisfaction with the treatment of patients

Non-specific infectious and inflammatory diseases of the spine are a rather rare pathology, which still remains a difficult problem for neurologists and neurosurgeons despite the advances in treatment achieved in last years. The outcome of the disease, in addition to the characteristics of the infectious agent and the clinical and morphological form of the disease is influenced by the early terms of diagnosis and surgical treatment. There is an analysis of 265 patients treated in the neurosurgical department for nonspecific diseases of the spine in the article. The long-term outcomes of treatment after decompression-sanitation and decompression-sanitation-stabilization operations were assessed on the basis of subjective (using standardized scales) and objective data. The relief of vertebral pain syndrome and neurological deficits, restoration of working capacity as early as possible after surgical treatment are the most important criteria for patient satisfaction with treatment. The decompression-sanitizing-stabilizing operations compared to decompression-sanitizing operations is accompanied by significantly lower residual pain syndrome and better regression of neurological deficit in the early and long-term period of surgical treatment, which helps to improve the quality of life and satisfaction of patients after surgery.

1. Kubrakov K. M., Migunova V.A. Spondylodiscitis: modern approaches to diagnosis and treatment. Bulletin of Vitebsk State Medical university. 2018; 17(1): 14–22. (In Russ.). http://dx.doi.org/10.22263/2312–4156.2018.1.14

2. Snopko S. V., Firsov S.A., Kornilova I. V., Tumorin L. S., SHevchenko V. p. Features of diagnosis and treatment of purulent spinal epiduritis. Spine surgery. 2015; 12(4): 84–87. (In Russ.). https://doi.org/10.14531/ss2015.4.84–87

3. Citak M., Backhaus M., Kälicke T., Hilal Z., Muhr G., Frangen T.M. Myths and facts of spondylodiscitis: an analysis of 183 cases. Acta Orthop Belg. 2011; 77: 535–538. PMID: 21954765

4. Kehrer M., Pedersen C., Jensen T. G., Hallas J., Lassen A.T. Increased short- and long-term mortality among patients with infectious spondylodiscitis compared with a reference population. Spine J. 2015; 15: 1233–1240. doi: 10.1016/j.spinee.2015.02.021

5. Goncharov M.Yu., Masyutina D. D. The syndrome of neurological disorders as a predictor of early diagnosis and a criterion for the effectiveness of surgical treatment of nonspecific purulent diseases of the spine. Bulletin of the Ural academic medical science. 2020;17:2; 175–186. (In Russ.).

6. Goncharov M.Yu., Levchik E.Yu. Optimization of anterior autologous fusion in the surgical treatment of nonspecific spondylodiscitis. Modern problems of science and education. 2020; 17:2; 175–186. (In Russ.)

7. Tihodeev S.A., Vishnevskij A.A. Long-term results of surgical treatment of nonspecific osteomyelitis of the spine. Surgery of the spine. (In Russ.). https://doi.org/10.14531/ss2007.1.52–59

8. Herren C., Jung N., pishnamaz M., Breuninger M., Siewe J., Sobottke R. Spondylodiscitis: diagnosis and treatment options: a systematic review. Dtsch Arztebl Int. 2017; 114. 875–882. https://doi.org/10.3238/arztebl.2017.0875

9. Bydon M., De la Garza-Ramos R., Macki M., Naumann M, Sciubba D. M., Wolinsky J. P., Bydon A., Gokaslan Z. L., Witham T.F. Spinal instrumentation in patients with primary spinal infections does not lead to greater recurrent infection rates: an analysis of 118 cases. World Neurosurg. 2014; 82: 807–814. https://doi.org/10.1016/j.wneu.2014.06.014

10. Eftimov, T., Ninov K., Prandjev V., Hadzhiangelov I., Marinov N. Results of surgicalt treatment in patients with primary non-specific spondylodicites. Bulg Neurosurg. 2014; 19: 21–28. https://doi.org/10.1055/s-0034–1382210

11. Park, K.H., Cho O. H., Jung M., Suk K. S., Lee J. H., Park J. S., Ryu K. N., Kim S. H., Lee S. O., Choi S. H. Clinical characteristics and outcomes of hematogenous vertebral osteomyelitis caused by gram-negative bacteria. J Infect. 2014:69. 42–46. https://doi.org/10.1016/j.jinf.2014.02.009